Madrigal is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of non-alcoholic steatohepatitis disease.
Business Model:
Revenue: $1M
Employees: 51-200
Madrigal was acquired by
Synta Pharmaceuticals.
The acquisition happend on 2016-04-14.
Details of the transaction were not public
Address: 200 Barr Harbor Drive
City: West Conshohocken
State: PA
Zip: 19428
Country: US
Madrigal is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of non-alcoholic steatohepatitis disease.
Contact Phone:
+16107561324
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/9/2007
Ticker Symbol:
MGDL
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2017 | Post-IPO Equity | $35M | 12/2022 | Post-IPO Equity | $259M | 5/2016 | Post-IPO Debt | $3.4M | 4/2016 | Debt | $3.4M | 6/2018 | Post-IPO Equity | $300M | 6/2017 | Private Placement | $35M | 12/2019 | Secondary Offering | $148.8M | 4/2014 | Post-IPO Equity | 1 | - |
Bay City Capital Bay City Capital |
5/2022 | Post-IPO Debt | 1 | $250M |
Hercules Capital Hercules Capital |
4/2014 | Post-IPO Equity | 1 | - |
Bay City Capital Bay City Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|